AI주식인사이트AI Stock Insight
B

동국생명과학

303810KOSDAQ의약품 제조업

57.8 / 100

Reference Date: 2026-06-10

Financial Score24.5 / 40
News Sentiment21.3 / 25
Momentum2.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Plunged 16.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Dongkook Life Science is a specialized contrast agent manufacturer focusing on X-ray, CT, and MRI imaging diagnostics, with iodinated and gadolinium-based contrast agents as core products. Driven by aging populations and rising diagnostic demand, the company has expanded its market share to 22.6% in 2024. It is diversifying its portfolio through medical equipment distribution and AI medical device expansion.

Number of Employees

203people

Average Salary

64.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
10.13Industry Average 11.935.0Point

In line with industry avg

PBR
0.68Industry Average 0.894.0Point

In line with industry avg

ROE
7.32Industry Average 4.015.5Point

1.8x industry avg (good)

Debt Ratio
4.26Industry Average 12.436.5Point

Half of industry avg (excellent)

Trend 2024~20253.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼1.1% (1-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲9.5% (1-year basis)

ROE Trend
1.0 / 4

Avg ROE 5.0% (improving, 2yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 2,785Won52-week high 5,15052-week low 2,785
1-month return0.0Point

1m -15.99% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral분기보고서 (2026.03)2026-05-14